BioCentury
ARTICLE | Financial News

Mirna raises $41.8M in series D

May 1, 2015 1:18 AM UTC

Mirna Therapeutics Inc. (Austin, Texas) raised $41.8 million in a series D round led by new investor Baxter Ventures. Other new investors included Eastern Capital; Sante Ventures; Morningside Ventures; Rock Springs Capital; and Celgene Corp. (NASDAQ:CELG). Existing investors Sofinnova Ventures; New Enterprise Associates; Pfizer Ventures; Osage University Partners; Correlation Ventures; and undisclosed others also participated. ...